• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受保乳治疗的绝经前和绝经后导管癌患者乳腺复发的危险因素。

Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy.

作者信息

Kurtz J M, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Roth J, Spitalier J M

机构信息

Department of Radiation Oncology, University Hospital, Basel, Switzerland.

出版信息

Cancer. 1990 Apr 15;65(8):1867-78. doi: 10.1002/1097-0142(19900415)65:8<1867::aid-cncr2820650833>3.0.co;2-i.

DOI:10.1002/1097-0142(19900415)65:8<1867::aid-cncr2820650833>3.0.co;2-i
PMID:2156607
Abstract

Risk factors for local failure were evaluated for 496 clinical Stage I-II patients with infiltrating ductal carcinomas (median follow-up, 71 months) treated by conservative surgery and radiotherapy. Monofactorial analysis identified the following factors to be correlated with increased risk: moderate/marked mononuclear cell reaction (MCR), high histologic grade (G), extensive intraductal component (EIC), tumor necrosis, macroscopic multiplicity, estrogen receptor negativity, anatomic tumor size, age younger than 40 years, and vascular invasion. Only MCR, G, and EIC proved significant in Cox multivariate analysis. These risk factors were highly age dependent, with EIC markedly more prevalent in women younger than 50, MCR and G in women younger than 40. Separate Cox analysis for premenopausal patients showed that MCR/EIC determined risk independent of resection margins: tumors with MCR had a 28%, and with EIC a 22% probability of recurring locally by 5 years. Premenopausal patients with neither risk factor had a very low failure rate (2.6% at 5 years), regardless of age. For postmenopausal patients risk of breast recurrence was determined both by adequacy of resection margins and grade, with a high local failure rate for patients having G3 tumors with positive or indeterminate margins (31% at 5 years). The authors conclude that the microscopic examination is the only useful tool for assessing the risk of local failure, which is quite low for the majority of patients treated with breast conservation. High-risk patients can be recognized morphologically. The age dependence of morphologic risk factors appears to explain the high local failure rate seen in patients younger than 40.

摘要

对496例浸润性导管癌临床I-II期患者进行了局部复发危险因素评估,这些患者接受了保乳手术和放疗(中位随访时间71个月)。单因素分析确定以下因素与风险增加相关:中度/显著单核细胞反应(MCR)、高组织学分级(G)、广泛导管内成分(EIC)、肿瘤坏死、肉眼可见多灶性、雌激素受体阴性、肿瘤解剖学大小、年龄小于40岁以及血管侵犯。在Cox多因素分析中,只有MCR、G和EIC被证明具有显著性。这些危险因素高度依赖年龄,EIC在50岁以下女性中明显更为普遍,MCR和G在40岁以下女性中更为普遍。对绝经前患者进行的单独Cox分析显示,MCR/EIC决定风险,与手术切缘无关:有MCR的肿瘤5年内局部复发概率为28%,有EIC的为22%。无论年龄如何,没有这些危险因素的绝经前患者复发率非常低(5年时为2.6%)。对于绝经后患者,乳腺复发风险由手术切缘的充分性和分级共同决定,切缘阳性或不确定的G3级肿瘤患者局部复发率较高(5年时为31%)。作者得出结论,显微镜检查是评估局部复发风险的唯一有用工具,对于大多数接受保乳治疗的患者来说,这种风险相当低。高危患者可以通过形态学识别。形态学危险因素的年龄依赖性似乎解释了40岁以下患者中较高的局部复发率。

相似文献

1
Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy.接受保乳治疗的绝经前和绝经后导管癌患者乳腺复发的危险因素。
Cancer. 1990 Apr 15;65(8):1867-78. doi: 10.1002/1097-0142(19900415)65:8<1867::aid-cncr2820650833>3.0.co;2-i.
2
An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy.对广泛导管内成分作为保乳治疗后局部复发风险因素的评估。
Br J Cancer. 1990 Jun;61(6):873-6. doi: 10.1038/bjc.1990.195.
3
Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy.早期乳腺癌:接受保乳手术和放射治疗患者的乳腺复发预测因素
Radiother Oncol. 1990 Sep;19(1):29-41. doi: 10.1016/0167-8140(90)90163-q.
4
The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy.接受保乳手术和放疗的Ⅰ期或Ⅱ期乳腺癌患者的最佳切除范围。
Ann Surg. 1991 Sep;214(3):200-4; discussion 204-5. doi: 10.1097/00000658-199109000-00002.
5
Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.淋巴结阴性乳腺癌保乳治疗后切缘对同侧乳腺肿瘤复发的影响。
Cancer. 2004 May 1;100(9):1823-32. doi: 10.1002/cncr.20153.
6
Why are local recurrences after breast-conserving therapy more frequent in younger patients?为什么保乳治疗后局部复发在年轻患者中更常见?
J Clin Oncol. 1990 Apr;8(4):591-8. doi: 10.1200/JCO.1990.8.4.591.
7
Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.保乳治疗对导管原位癌患者的疗效改善。
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e581-6. doi: 10.1016/j.ijrobp.2011.08.015. Epub 2011 Dec 28.
8
Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy.保乳治疗患者的病理切缘受累情况及复发风险
Cancer. 1996 Nov 1;78(9):1921-8. doi: 10.1002/(sici)1097-0142(19961101)78:9<1921::aid-cncr12>3.0.co;2-#.
9
Breast conservative surgery and local recurrence.保乳手术与局部复发
Breast. 2015 Nov;24 Suppl 2:S100-7. doi: 10.1016/j.breast.2015.07.024. Epub 2015 Oct 1.
10
The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer.广泛导管内成分(EIC)对早期激素受体阳性乳腺癌复发的基因组风险的影响。
Breast. 2024 Oct;77:103777. doi: 10.1016/j.breast.2024.103777. Epub 2024 Jul 14.

引用本文的文献

1
Extensive intraductal component as a factor determining local recurrence of breast cancer: a systematic review and meta-analysis.广泛导管内成分作为决定乳腺癌局部复发的一个因素:一项系统评价和荟萃分析
Gland Surg. 2023 Oct 30;12(10):1336-1347. doi: 10.21037/gs-23-137. Epub 2023 Oct 26.
2
Mammographic calcification can predict outcome in women with breast cancer treated with breast-conserving surgery.乳腺钼靶钙化可预测接受保乳手术治疗的乳腺癌女性的预后。
Oncol Lett. 2017 Jul;14(1):79-88. doi: 10.3892/ol.2017.6112. Epub 2017 May 3.
3
Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer.
导管原位癌成分的存在及数量对浸润性乳腺癌预后的影响。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):13304-13. eCollection 2015.
4
Breast cancer local therapy: what is its effect on mortality?乳腺癌局部治疗:其对死亡率有何影响?
World J Surg. 2012 Jul;36(7):1460-74. doi: 10.1007/s00268-012-1468-5.
5
Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up.保乳术后乳腺癌患者的适形放疗:7 年随访。
Med Oncol. 2012 Dec;29(4):2570-6. doi: 10.1007/s12032-012-0192-1. Epub 2012 Feb 22.
6
Intraoperative radiotherapy in the treatment of breast cancer: a review of the evidence.术中放疗治疗乳腺癌:证据综述
Int J Breast Cancer. 2011;2011:375170. doi: 10.4061/2011/375170. Epub 2011 Jun 1.
7
Audit of local recurrence following breast conservation surgery with 5-mm target margin and hypofractionated 40-Gray breast radiotherapy for invasive breast cancer.对浸润性乳腺癌采用5毫米切缘目标及40格雷大分割乳腺放疗的保乳手术后局部复发情况的审计。
Ann R Coll Surg Engl. 2010 Oct;92(7):562-8. doi: 10.1308/003588410X12699663903476. Epub 2010 Jun 1.
8
Recent developments in breast-conserving surgery for breast cancer patients.乳腺癌患者保乳手术的最新进展。
Langenbecks Arch Surg. 2009 Jul;394(4):591-609. doi: 10.1007/s00423-008-0412-5. Epub 2008 Sep 10.
9
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence.乳腺癌局部复发:早期复发的危险因素及预后相关性
World J Surg. 2007 Jan;31(1):36-45. doi: 10.1007/s00268-006-0097-2.
10
Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics.不可触及的乳腺癌的乳腺X线表现反映了病理特征。
Ann Surg. 2002 Feb;235(2):246-51. doi: 10.1097/00000658-200202000-00013.